John Lewis
Somerset, KY *2501-1848
abm9ou@r.postjobfree.com
Career Objective: To obtain a sales/management position
Education: BA Business-Finance, Eastern Kentucky University
Experience: SERPRO INC. Sales Marketing Representative. 8/09-
Present. Delivering sales presentations, consultations, and
estimates for water mitigation and fire restoration services.
I call on insurance agents, adjusters, high profile public and
private employees, corporations and homeowners. Some calls
require a one call close in order to secure a potential high
five figure or low to mid six figure water or fire loss. First
sales call yielded an $8,000 water damage job and I made over
$21,000 in 3 days during storm duty. I am averaging $60,000 in
sales per month.
ABBOTT LABS. Pain Consultant. 9/08-8/09. Promoting Synthroid
and Vicoden CR. Vicoden CR did not get FDA approval and the
sales force was eliminated. I gained commitments from
healthcare providers even though I didn't have a sales aid or
package insert. Proper use and potential abuse were discussed
and campaigns such as Not In My House and Partnership for a
Drug Free America were promoted.
OSCIENT PHARMACEUTICALS. Lipid-Cardiovascular Consultant.
04/07-5/08. Territory Manager promoting Antara and Factive.
The following are my accomplishments:
Grew Antara New Rx share from 2.97% to 6.18% 4Q 07
1st in District NRxs for Antara 4Q 07
4th in District Share Growth for Antara 4Q 07
2nd in District New Rxs for Antara 4Q 07
2nd in District NRx Volume for Antara 4Q 07
3rd in District NRx Share Growth for Factive 4Q 07
PROFESSIONAL DETAILING INC. from 10/01-12/06. I promoted
pharmaceuticals for ELI LILLY, ASTRAZENECA AND
GLAXOSMITHKLINE. For GSK I promoted Advair, Coreg, Paxil CR,
Avodart, Malarone and Requip from 01/05-12/06. I helped RE-
LAUNCH Paxil CR and Requip. For AstraZeneca I was a
Pharmaceutical Sales Specialist promoting Crestor and Nexium
from 2/04-12/04. Lastly, I was on the Eli Lilly contract
promoting Evista, Ceftin, Quixin, Welchol and Lotensin from
10/01-02/03. The following are my accomplishments:
1st in district Paxil CR market share growth, 4Q 05 (GSK)
2nd in district Advair market share growth, 2Q 06 (GSK)
3rd in district market share growth for Requip, Advair &
Avodart, 2Q 06 (GSK)
3rd in the nation for Requip, Advair & Avodart, 3Q 06 (GSK)
2nd in the region for Nexium market share growth, 2nd Q 04
(AZ)
64th out of 510 nationally for Evista (Eli Lilly)
30th nationally for Lotensin market growth, Oct. of 02 (Eli
Lilly)